Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.
2021
111
LTM Revenue $13.7M
LTM EBITDA -$39.1M
$20.0M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Hyperfine has a last 12-month revenue of $13.7M and a last 12-month EBITDA of -$39.1M.
In the most recent fiscal year, Hyperfine achieved revenue of $12.9M and an EBITDA of -$42.2M.
Hyperfine expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Hyperfine valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $11.0M | $12.9M | XXX | XXX | XXX |
Gross Profit | $0.9M | $4.8M | XXX | XXX | XXX |
Gross Margin | 8% | 37% | XXX | XXX | XXX |
EBITDA | -$47.1M | -$42.2M | XXX | XXX | XXX |
EBITDA Margin | -427% | -328% | XXX | XXX | XXX |
Net Profit | -$73.2M | -$44.2M | XXX | XXX | XXX |
Net Margin | -663% | -343% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Hyperfine's stock price is $1.
Hyperfine has current market cap of $57.3M, and EV of $20.0M.
See Hyperfine trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$20.0M | $57.3M | XXX | XXX | XXX | XXX | $-0.53 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Hyperfine has market cap of $57.3M and EV of $20.0M.
Hyperfine's trades at 1.5x LTM EV/Revenue multiple, and -0.5x LTM EBITDA.
Analysts estimate Hyperfine's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Hyperfine and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $20.0M | XXX | XXX | XXX |
EV/Revenue | 1.5x | XXX | XXX | XXX |
EV/EBITDA | -0.5x | XXX | XXX | XXX |
P/E | -1.4x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | -0.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpHyperfine's NTM/LTM revenue growth is 24%
Hyperfine's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.4M for the same period.
Over next 12 months, Hyperfine's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Hyperfine's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Hyperfine and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 17% | XXX | XXX | XXX | XXX |
EBITDA Margin | -328% | XXX | XXX | XXX | XXX |
EBITDA Growth | -10% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | -304% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.4M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 71% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 136% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 175% | XXX | XXX | XXX | XXX |
Opex to Revenue | 381% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Hyperfine acquired XXX companies to date.
Last acquisition by Hyperfine was XXXXXXXX, XXXXX XXXXX XXXXXX . Hyperfine acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Hyperfine founded? | Hyperfine was founded in 2021. |
Where is Hyperfine headquartered? | Hyperfine is headquartered in United States of America. |
How many employees does Hyperfine have? | As of today, Hyperfine has 111 employees. |
Who is the CEO of Hyperfine? | Hyperfine's CEO is Ms. Maria Sainz. |
Is Hyperfine publicy listed? | Yes, Hyperfine is a public company listed on NAS. |
What is the stock symbol of Hyperfine? | Hyperfine trades under HYPR ticker. |
When did Hyperfine go public? | Hyperfine went public in 2021. |
Who are competitors of Hyperfine? | Similar companies to Hyperfine include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of Hyperfine? | Hyperfine's current market cap is $57.3M |
What is the current revenue of Hyperfine? | Hyperfine's last 12-month revenue is $13.7M. |
What is the current EBITDA of Hyperfine? | Hyperfine's last 12-month EBITDA is -$39.1M. |
What is the current EV/Revenue multiple of Hyperfine? | Current revenue multiple of Hyperfine is 1.5x. |
What is the current EV/EBITDA multiple of Hyperfine? | Current EBITDA multiple of Hyperfine is -0.5x. |
What is the current revenue growth of Hyperfine? | Hyperfine revenue growth between 2023 and 2024 was 17%. |
Is Hyperfine profitable? | Yes, Hyperfine is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.